This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Regeneron Pharmaceuticals, Inc.. Active years: 2023.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2023
Title: Trikaldarshi Persaud: Innovator in Ophthalmic Treatments
Introduction
Trikaldarshi Persaud is a notable inventor based in Tarrytown, NY (US). He has made significant contributions to the field of ophthalmology through his innovative research and development.
Latest Patents
Trikaldarshi holds a patent for the "Treatment of ophthalmic conditions with angiopoietin-like 7 (ANGPTL7) inhibitors." This patent outlines methods for treating patients with ophthalmic conditions, identifying subjects at risk of developing such conditions, and detecting human ANGPTL7 variant nucleic acid molecules and polypeptides. His work in this area is crucial for advancing treatment options for patients suffering from various eye disorders.
Career Highlights
Trikaldarshi is currently employed at Regeneron Pharmaceuticals, Inc., where he continues to push the boundaries of medical research. His dedication to improving patient outcomes through innovative therapies is evident in his work and contributions to the field.
Collaborations
He collaborates with esteemed colleagues, including Aris I Baras and Claudia Schurmann, to further enhance the impact of his research and innovations.
Conclusion
Trikaldarshi Persaud's work exemplifies the spirit of innovation in the medical field, particularly in ophthalmology. His contributions through patents and collaborations are paving the way for new treatment methodologies that can significantly benefit patients.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile